Richard Kuntz

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Minneapolis, MN
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Ed Kirnbauer, Attorney in Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Richard Kuntz

Form 4 holding SVP & Chief Medical & Science

Medtronic plc

Security class
Ordinary Shares
Shares / value
74,945
Estimated value
$6,158,231
Report date
05 Nov 2021
Price
$82.17
Ownership
Direct
Form 4 holding Director

ZimVie Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
$675,436
Report date
20 Oct 2025
Price
$18.45
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ZimVie Inc.

Security class
Deferred Share Units
Shares / value
0
Estimated value
$128,951
Report date
20 Oct 2025
Price
$12.20
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

DiaMedica Therapeutics Inc.

Security class
Voting Common Shares, no par value per share
Shares / value
14,285
Estimated value
$39,998
Report date
01 Jun 2024
Price
$2.80
Ownership
Direct
Form 4 holding Director

Rockley Photonics Holdings Ltd

Security class
Restricted Stock Unit
Shares / value
60,837
Estimated value
Report date
08 Aug 2022
Price
Ownership
Direct
Underlying class
Ordinary Share
Underlying amount

Insider Reports Filed by Richard Kuntz

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .